Table 3:

Secondary outcomes in intent-to-treat analysis

	CA (n = 111)	SAC (n = 94)	RR (95% CI)	P Value
Hospitalization			0.78 (0.48–1.28)	.325
Patients hospitalized for >3 days (No.) (%)	30 (27.3)	20 (21.3)
Discharge location (No.) (%)			1.18 (0.35–3.96)	.788
Home	106 (95.5)	89 (94.7)
Other than home	5 (4.5)	5 (5.3)
Other hospital	1 (0.9)	0
Rehabilitation center	2 (1.8)	2 (2.1)
Death	2 (1.8)	3 (3.2)
mRS at discharge (No.) (%)			1.18 (0.35–3.96)	.788
0	84 (75.7)	69 (73.4)
1	17 (15.3)	16 (17.0)
2	5 (4.5)	4 (4.3)
3	2 (1.8)	1 (1.1)
4	1 (0.9)	0 (0.0)
5	0 (0.0)	1 (1.1)
6	2 (1.8)	3 (3.2)
1 -Year mRS (No.) (%)			1.17 (0.43–3.22)	.761
0	66 (60.0)	54 (57.4)
1	30 (27.3)	26 (27.7)
2	7 (6.4)	7 (7.4)
3	1 (0.9)	2 (2.1)
4	2 (1.8)	0 (0.0)
5	1 (0.9)	0 (0.0)
6	3 (2.7)	5 (5.3)
Missing mRS data	1 (0.9)	0
Time of 1-year mRS assessment (mean) (SD) (mo)	15.7 (10.5)	15.3 (8.0)
Morbidity and mortality at 1 year (mRS > 2), (No.) (%)	6 (5.4%)	8 (8.5%)
Retreatment of index aneurysm during follow-up (No.) (%)	0	3 (3.2)
Immediate angiographic outcome			0.97 (0.42–2.23)	.936
Complete occlusion (No.) (%)	67 (60.4)	55 (58.5)
Residual neck (No.) (%)	33 (29.7)	30 (31.9)
Residual saccular aneurysm (No.) (%)	11 (9.9)	9 (9.6)
Angiographic outcome at 1 year (core lab) (Detailed results in Online Supplemental Data)
Complete occlusion (No.) (%)	38 (34.2)	42 (44.7)
Residual neck (No.) (%)	43 (38.7)	24 (25.5)
Residual saccular aneurysm (No.) (%)	27 (24.3)	24 (25.5)
1-year imaging not available^{^a} (No.) (%)	3 (2.7)	4 (4.3)
Time of 1-year imaging assessment (mean) (SD) (mo)	13.5 (5.2)	14.8 (9.5)
Follow-up vascular imaging^{^a} (No.) (%)	108 (97.3)	90 (95.7)
MRA (No.) (%)	82 (73.9)	53 (56.4)
Catheter angiography (No.) (%)	24 (21.6)	35 (37.2)
CTA (No.) (%)	2 (1.8)	2 (2.1)

↵a Three deaths in the CA group, 4 deaths in the SAC group. For 1 patient in the SAC group (who died 298 days after treatment), the 1-year imaging was adjudicated using the 3-month follow-up angiogram.